Inflammatory and anti-inflammatory cytokines bidirectionally modulate amygdala circuits regulating anxiety., PMID:40199321
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders., PMID:39875232
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels., PMID:39525315
Evaluation of inflammatory biomarkers and their association with anti-SARS-CoV-2 antibody titers in healthcare workers vaccinated with BNT162B2., PMID:39247198
Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls., PMID:39165841
Fragile Guts Make Fragile Brains: Intestinal Epithelial Nrf2 Deficiency Exacerbates Neurotoxicity Induced by Polystyrene Nanoplastics., PMID:39158845
Multiarray screening identifies plasma proteins associated with Th17 cell differentiation and viral defense in coincident asthma and obesity., PMID:38967090
IL-17C neutralization protects the kidney against acute injury and chronic injury., PMID:37263138
Plasma protein changes reflect colorectal cancer development and associated inflammation., PMID:37228491
Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis., PMID:36498818
Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36γ and IL-17C in Human Keratinocytes., PMID:36496195
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19., PMID:35479098
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study., PMID:34687214
Epicutaneous challenge with protease allergen requires its protease activity to recall TH2 and TH17/TH22 responses in mice pre-sensitized via distant skin., PMID:34487475
Pityriasis Rubra Pilaris Response to IL-17A Inhibition Is Associated with IL-17C and CCL20 Protein Levels., PMID:34246621
Acute FPIES reactions are associated with an IL-17 inflammatory signature., PMID:33891982
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer., PMID:33244315
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)., PMID:32939860
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers., PMID:32849633
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study., PMID:32416208
IL-17C has a pathogenic role in kidney ischemia/reperfusion injury., PMID:32331702
Brodalumab: A new way to inhibit IL-17 in psoriasis., PMID:32285564
Immune Responses and Protective Efficacy of a Formalin-Killed Francisella Noatunensis Subsp. Orientalis Vaccine Evaluated through Intraperitoneal and Immersion Challenge Methods in Oreochromis Niloticus., PMID:32260212
IL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology., PMID:32174926
Human Cytomegalovirus (HCMV) Reactivation in the Mammary Gland Induces a Proinflammatory Cytokine Shift in Breast Milk., PMID:32093317
IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema., PMID:31793105
Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and Etanercept., PMID:31705874
Serum biomarker analysis in patients with premature ovarian insufficiency., PMID:31629109
New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines., PMID:31622669
Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review., PMID:31372022
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date., PMID:31118733
Population pharmacokinetics of brodalumab in patients with moderate to severe plaque psoriasis., PMID:30661290
IL-17 inhibitors for psoriasis., PMID:30215631
TSLP Protects Corneas From Pseudomonas aeruginosa Infection by Regulating Dendritic Cells and IL-23-IL-17 Pathway., PMID:30128494
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond., PMID:30127781
IL-17C: A Unique Epithelial Cytokine with Potential for Targeting across the Spectrum of Atopic Dermatitis and Psoriasis., PMID:29941097
IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation., PMID:29483158
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis., PMID:29474945
Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model., PMID:29282132
TLN-58, an Additional hCAP18 Processing Form, Found in the Lesion Vesicle of Palmoplantar Pustulosis in the Skin., PMID:27771329
TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients., PMID:27376466
Interleukin-9 and interleukin-17C in chronic rhinosinusitis., PMID:26989880
Characterization of Lamprey IL-17 Family Members and Their Receptors., PMID:26491201
CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin., PMID:25828150
IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease., PMID:25299544
Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody., PMID:24646743
Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels., PMID:23954997
IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer., PMID:23834281
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation., PMID:23359500
Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy., PMID:20846304
For research use only. Not for human or drug use.
